TechRadars: colgate, pharma’s next big Pharma?
Is there a trend towards smaller pharma companies?
The story of a couple of mega-companies, which are trying to be the next big thing.
The company was founded in 2008, and has a market cap of around $9 billion.
Its chief executive, Alex Belsky, recently said that the company is currently working on a new drug to treat depression, which is currently being developed in collaboration with Pfizer.
But Colgate’s success is not guaranteed.
The company has been hit with a $30 billion class action lawsuit from shareholders who claim the company has overcharged them for treatment.